ArticleBioengineering (Basel, Switzerland)2025
Assessing Particle Release from Intraocular Lenses with a Combination of OptoFluidic Force Induction, μ-Raman and μ-FTIR.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Intraocular lenses (IOLs) are among the most common medical implants that remain in the body long-term, with millions of IOLs implanted into patients every year. In addition, there are rapidly growing concerns about microplastic pollution, including particle emission from medical implants directly inside the body. Against this backdrop, we analyze the particle emission of seven common types of IOLs over a 30-day period under laboratory conditions. To accomplish both particle counting over a long period and chemical identification, we combine OptoFluidic Force Induction (OF2i), a novel online particle counting method, with micro Fourier Transform Infrared Spectroscopy with Attenuated Total Reflection (μ-FTIR-ATR) and Raman microscopy. Encouragingly, over the 30-day period, no significant particle emission from the IOLs was detectable. Neither was any increase in particle count detectable by OF2i, nor could any particle related to IOL material be found out of over 500 particles analyzed on non-control samples by FTIR and Raman microscopy. The most notable limitation of these results is the 30-day period, which is short compared to the time an IOL stays in the patient, which can be years or even decades. However, two of the tested IOLs were stored in liquid in their original packaging, the analysis of which represents a less-controlled long-term version of our study. Whilst microplastic contamination was found in these liquids, the FTIR and Raman analysis showed that it relates to the packaging materials (PE, PP) rather than the IOLs (acrylic), pointing to a high stability of the IOLs. Future work should try to assess longer time frames with accelerated aging (thermal/UV/oxidative conditions) to approximate long-term in vivo scenarios. Moreover, our findings highlight the need for manufacturers to ensure maximum stability of packaging materials and packaging methods to minimize potential microplastic contamination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.